Literature DB >> 16961462

The C-terminus of CIS defines its interaction pattern.

Delphine Lavens1, Peter Ulrichts, Dominiek Catteeuw, Kris Gevaert, Joël Vandekerckhove, Frank Peelman, Sven Eyckerman, Jan Tavernier.   

Abstract

Proteins of the SOCS (suppressors of cytokine signalling) family are characterized by a conserved modular structure with pre-SH2 (Src homology 2), SH2 and SOCS-box domains. Several members, including CIS (cytokine-inducible SH2 protein), SOCS1 and SOCS3, are induced rapidly upon cytokine receptor activation and function in a negative-feedback loop, attenuating signalling at the receptor level. We used a recently developed mammalian two-hybrid system [MAPPIT (mammalian protein-protein interaction trap)] to analyse SOCS protein-interaction patterns in intact cells, allowing direct comparison with biological function. We find that, besides the SH2 domain, the C-terminal part of the CIS SOCS-box is required for functional interaction with the cytokine receptor motifs examined, but not with the N-terminal death domain of the TLR (Toll-like receptor) adaptor MyD88. Mutagenesis revealed that one single tyrosine residue at position 253 is a critical binding determinant. In contrast, substrate binding by the highly related SOCS2 protein, and also by SOCS1 and SOCS3, does not require their SOCS-box.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16961462      PMCID: PMC1698688          DOI: 10.1042/BJ20060242

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.

Authors:  J G Zhang; A Farley; S E Nicholson; T A Willson; L M Zugaro; R J Simpson; R L Moritz; D Cary; R Richardson; G Hausmann; B T Kile; B J Kile; S B Kent; W S Alexander; D Metcalf; D J Hilton; N A Nicola; M Baca
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma.

Authors:  D Stoiber; P Kovarik; S Cohney; J A Johnston; P Steinlein; T Decker
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

3.  Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.

Authors:  A Matsumoto; Y Seki; M Kubo; S Ohtsuka; A Suzuki; I Hayashi; K Tsuji; T Nakahata; M Okabe; S Yamada; A Yoshimura
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells.

Authors:  Andrea Baetz; Markus Frey; Klaus Heeg; Alexander H Dalpke
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

5.  Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling.

Authors:  Sébastien Gingras; Evan Parganas; Antoine de Pauw; James N Ihle; Peter J Murray
Journal:  J Biol Chem       Date:  2004-10-18       Impact factor: 5.157

6.  SOCS2 negatively regulates growth hormone action in vitro and in vivo.

Authors:  Christopher J Greenhalgh; Elizabeth Rico-Bautista; Mattias Lorentzon; Anne L Thaus; Phillip O Morgan; Tracy A Willson; Panagiota Zervoudakis; Donald Metcalf; Ian Street; Nicos A Nicola; Andrew D Nash; Louis J Fabri; Gunnar Norstedt; Claes Ohlsson; Amilcar Flores-Morales; Warren S Alexander; Douglas J Hilton
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.

Authors:  P De Sepulveda; K Okkenhaug; J L Rose; R G Hawley; P Dubreuil; R Rottapel
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

8.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.

Authors:  S E Nicholson; T A Willson; A Farley; R Starr; J G Zhang; M Baca; W S Alexander; D Metcalf; D J Hilton; N A Nicola
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

9.  Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein.

Authors:  F Verdier; S Chrétien; O Muller; P Varlet; A Yoshimura; S Gisselbrecht; C Lacombe; P Mayeux
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.

Authors:  R Suzuki; H Sakamoto; H Yasukawa; M Masuhara; T Wakioka; A Sasaki; K Yuge; S Komiya; A Inoue; A Yoshimura
Journal:  Oncogene       Date:  1998-10-29       Impact factor: 9.867

View more
  2 in total

1.  The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.

Authors:  Jeffrey J Babon; Jennifer K Sabo; Alfreda Soetopo; Shenggen Yao; Michael F Bailey; Jian-Guo Zhang; Nicos A Nicola; Raymond S Norton
Journal:  J Mol Biol       Date:  2008-06-20       Impact factor: 5.469

2.  IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells.

Authors:  M L B Jacobsen; S G Rønn; C Bruun; C M Larsen; D L Eizirik; T Mandrup-Poulsen; N Billestrup
Journal:  Diabetologia       Date:  2008-11-11       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.